ARTICLES PUBLISHED IN PEER-REVIEWED JOURNALS
2026
INVESTIGATING DIGITAL OUTCOMES (INDIGO) A RANDOMISED OBSERVATIONAL DIGITAL TRIAL: RESULTS OF PILOT STUDY (PREPRINT)
April 20, 2026
Le Calvez K, Williams MH, Gregory JJ, Mauricaite R, Mickiewicz G, Gath J, Wheatstone P, Pakzad-Shahabi L, Ashley L, Chinembiri O, Cunliffe A, Davenport G, Jamieson Gilmore K, Langel K, Miglio C, Padmasri D, Ruta D, Williams H
2025
BEAT-BREAST: IMPROVING OUTCOMES FOR BREAST CANCER PATIENTS WITH BRAIN METASTASES A NON-RANDOMISED MULTI-CENTRE PHASE 2 FEASIBILITY TRIAL IN PATIENTS WITH PRIMARY BREAST CANCER WITH BRAIN METASTASES WHO ARE NOT SUITABLE FOR STEREOTACTIC RADIOTHERAPY
September 2025
Pakzad-Shahabi L, Ho A, Thompson S, Merritt G, Merritt V, Gleason K, Dodwell D, Valiente M, Shaw J, Grosu A-L, Dixon L, Smith J, Vinayan A, Williams M
PELVIC STEREOTACTIC ABLATIVE BODY RADIOTHERAPY (SABR) REIRRADIATION: UK SABR CONSORTIUM GUIDANCE FOR USE IN ROUTINE CLINICAL CARE
September 2025
Moreno-Olmedo E, Owczarczyk K, Chadwick E, Dickinson P, Duffton A, Jones B, Good JS, McDonald F, Murray LJ, Rackley T, Robinson M, Sinclair J, Strawson-Smith T, Tree A, Tsang YM, Zarkar A, Dean C, Diez P, Williams M, Andratschke N, Muirhead R
A HYBRID FLUOROPIVALATE PET-MULTIPARAMETRIC MRI TO DETECT AND CHARACTERISE BRAIN TUMOUR METASTASES BASED ON A PERMISSIVE ENVIRONMENT FOR MONOCARBOXYLATE TRANSPORT
February 7, 2025
Islam S, Inglese M, Aravind P, Barwick T, Mauri F, McLeavy L, Arstad E, Wang J, Puccio I, Hung L, Lu H, O'Neill K, Waldman AD, Williams M, Aboagye E
2024
DEVELOPING A FUNCTIONAL PRECISION MEDICINE ASSAY TO PREDICT PATHOLOGICAL COMPLETE RESPONSE IN PATIENTS WITH TRIPLE-NEGATIVE BREAST CANCER: INTERIM RESULTS FROM THE PEAR-TNBC TRIAL
October 27, 2024
Hall P, Williams M, Peerani E, Tham E, Iori F, de Fraine GRTB, Loughrey K, Kaffa AD, Richardson TDL, Liberal C, Velentza-Almpani A, Wiskerke DA, Sangkolah F, Crawley AM, Kearney J, Bah NK, Tasoulis MK, Kirwan CC, Cleator S, Chan S, Ranatunga D
GLIOBLASTOMA IN THE UK POST WHO CNS 5: INITIAL FINDINGS FROM THE HISTO-MOL GBM COLLABORATIVE
October 15, 2024
Robinson S, Ryan K, Black L, Forner S, Hatton NL, Hatton R, Aktar N, Lathangue H, Conkey D, Durage P, Macarthur R, Teoh M, Choudhury M, Bowman M, Cavalli C, de Luna P, Christodoulou P, Hill T, Williams A, Golten J, Aghadiuno T, Yogalingam K, Lau S, Kahan J, Dixit S, Guglani S, Williams M, Lewis R, Moleron R, Iqbal N, Wadd N, Lord H, Bhat P, Giamas G, Lorimer C, Chandy E, Critchley G
GLIOBLASTOMA AND RADIOTHERAPY: A MULTICENTER AI STUDY FOR SURVIVAL PREDICTIONS FROM MRI (GRASP STUDY)
June 3, 2024
Chelliah A, Wood DA, Canas LS, Shuaib H, Currie S, Fatania K, Frood R, Rowland-Hill C, Thust S, Wastling SJ, Tenant S, McBain C, Foweraker K, Williams M, Wang Q, Roman A, Dragos C, MacDonald M, Lau YH, Linares CA, Bassiouny A, Luis A, Young T, Brock J, Chandy E, Beaumont E, Lam T-C, Welsh L, Lewis J, Mathew R, Kerfoot E, Brown R, Beasley D, Glendenning J, Brazil L, Swampillai A, Ashkan K, Ourselin S, Modat M, Booth TC
2023
2022
FUTURE-GB: FUNCTIONAL AND ULTRASOUND-GUIDED RESECTION OF GLIOBLASTOMA – A TWO-STAGE RANDOMISED CONTROL TRIAL
November 15, 2022
Puneet Plaha, Sophie Camp, Jonathan Cook, Peter McCulloch, Natalie Voets, Ruichong Ma, Martin J B Taphoorn, Linda Dirven, Matthew Grech-Sollars, Colin Watts, Helen Bulbeck, Michael D Jenkinson, Matthew Williams, Adrian Lim, Luke Dixon, Stephen John Price, Keyoumars Ashkan, Vasileios Apostolopoulos, Vicki S Barber, Amy Taylor, FUTURE-GB collaborators, Dipankar Nandi
2021
2020
PRIORITISATION BY FIT TO MITIGATE THE IMPACT OF DELAYS IN THE 2-WEEK WAIT COLORECTAL CANCER REFERRAL PATHWAY DURING THE COVID-19 PANDEMIC: A UK MODELLING STUDY
August 27, 2020
Chey Loveday, Amit Sud, Michael E Jones, John Broggio, Stephen Scott, Firza Gronthound, Beth Torr, Alice Garrett, David L Nicol, Shaman Jhanji, Stephen A Boyce, Matthew Williams, Claire Barry, Elio Riboli, Emma Kipps, Ethna McFerran, David C Muller, Georgios Lyratzopoulos, Mark Lawler, Muti Abulafi, Richard S Houlston, Clare Turnbull,
EFFECT OF DELAYS IN THE 2-WEEK-WAIT CANCER REFERRAL PATHWAY DURING THE COVID-19 PANDEMIC ON CANCER SURVIVAL IN THE UK: A MODELLING STUDY
July 20, 2020
Amit Sud, Bethany Torr, Michael E Jones, John Broggio, Stephen Scott, Chey Loveday, Alice Garrett, Firza Gronthoud, David L Nicol, Shaman Jhanji, Stephen A Boyce, Matthew Williams, Elio Riboli, David C Muller, Emma Kipps, James Larkin, Neal Navani, Charles Swanton, Georgios Lyratzopoulos, Ethna McFerran, Mark Lawler, Richard Houlston, Clare Turnbull
COLLATERAL DAMAGE: THE IMPACT ON OUTCOMES FROM CANCER SURGERY OF THE COVID-19 PANDEMIC
May 19, 2020
A Sud, M E Jones, J Broggio, C Loveday, B Torr, A Garrett, D L Nicol, S Jhanji, S A Boyce, F Gronthoud, P Ward, J M Handy, N Yousaf, J Larkin, Y-E Suh, S Scott, P D P Pharoah, C Swanton, C Abbosh, M Williams, G Lyratzopoulos, R Houlston, C Turnbull
2019
INTEGRATED SYSTEMS-GENETIC ANALYSES REVEAL A NETWORK TARGET FOR DELAYING GLIOMA PROGRESSION
August 17, 2019
Laaniste L, Srivastava PK, Stylianou J, Syed N, Cases-Cunillera S, Shkura K, Zeng Q, Rackham OJL, Langley SR, Delahaye-Duriez A, O'Neill K, Williams M, Becker A, Roncaroli F, Petretto E, Johnson MR
2018
A STUDY OF THE FOCAL ADHESION KINASE INHIBITOR GSK2256098 IN PATIENTS WITH RECURRENT GLIOBLASTOMA WITH EVALUATION OF TUMOR PENETRATION OF [11C]GSK2256098
May 17, 2018
Brown NF, Williams M, Arkenau HT, Fleming RA, Tolson J, Yan L, Zhang J, Singh R, Auger KR, Lenox L, Cox D, Lewis Y, Plisson C, Searle G, Saleem A, Blagden S, Mulholland P